Summit NW Selects Implant Sciences' QS-B220 Trace Detection System for Air Cargo Screening
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it has sold its Quantum Sniffer™ QS-B220 desktop explosives trace detector to Summit NW Corporation. Summit NW, a Portland, Oregon-based trucking company in the northwest with Certified Cargo Screening Facility (CCSF) operations will use the QS-B220 for air cargo screening in its new facility.
Having recently seen the QS-B220 demonstrated at the AirCargo 2013 conference in Las Vegas last month, Summit NW was impressed with its performance and quickly reached a purchase decision. The QS-B220 was approved for air cargo screening by the Transportation Security Administration in January 2013.
Global C4ISR Industry 2016 Market Research Report
Sabine Morris, Vice President of Operations at Summit NW commented, "The QS-B220 offers an impressive combination of advanced technology such as automatic internal calibration, ease-of-use, and low total cost of ownership. Everything we've seen shows that it will be operationally superior to our existing systems. Deploying it in the new facility for our explosives trace detection needs was simply a better business decision."
"The AirCargo conference was our opportunity to showcase the QS-B220 just after having received TSA approval. We received a tremendous amount of interest at the conference, which is now starting to translate into sales. We look forward to working with Summit NW and serving their growing needs," stated Implant Sciences' Vice President of Sales and Marketing, Dr. Darryl Jones.
Source : Implant Sciences Corp.
Mar 20, 2017 - Singapore, Singapore